In our hospital, when multiple sinus occlusions and a delay in circulation time are observed in cases of sinus thrombosis, local fibrinolytic therapy (LFT) is used adjunctively with the continuous infusion of heparin, irrespective of disease severity. In this study, we examined the usefulness of LFT in sinus thrombosis. Fifteen consecutive patients (age range: 25‒61 years, mean: 45.3 years; 8 males and 7 females) diagnosed with sinus thrombosis based on CT/MRI findings were included in this study. Of these patients, one had a cerebral infarction, and six experienced cerebral hemorrhage. The superior sagittal/transverse-sigmoid/straight sinuses were affected in five cases, the superior sagittal sinus in three cases, and the transverse-sigmoid sinuses in seven cases. The symptoms observed were as follows: headache in six cases, consciousness disturbance in five cases, aphasia in two cases, and convulsion in two cases. The underlying causes were as follows: contraceptive use in three cases, malignancy in two cases, coagulation disorder in two cases, and infection in two cases. In six cases, the underlying cause was unknown. Local fibrinolysis was used when multiple sinus occlusions and a delay in circulation time were noted. Based on this criterion, six patients were treated with LFT, and nine with only heparin treatment. A maximum of 360,000 units of urokinase (UK) were administered as part of the LFT, and additional mechanical disruption was also performed; heparin was administered such that the activated partial thromboplastin time reached approximately 1.5 times the previous value. If partial recanalization was achieved, LFT was discontinued. In the LFT group, the average quantity of UK administered was 260,000 units. In this group, three out of six patients were treated using a balloon catheter for clot disruption. Partial recanalization was obtained in all cases, and no complications were observed. Outcomes evaluated using the modified Rankin Scale (mRS) 90 days post-treatment revealed that in total, there were eight patients with an mRS score of 0, four with a score of 1, one with a score of 2, one with a score of 3, and one with a score of 4. Thirteen cases (87%) showed a favorable mRS outcome of 0‒2, and the two cases with an mRS result of 3‒4 were in the heparin treatment group. It is useful to combine heparin therapy with early LFT for sinus thrombosis with multiple sinus occlusions, irrespective of disease severity. LFT was considered not to aim for complete recanalization, but to be positioned as an adjuvant therapy and keep safe procedure, and it was concluded that good results were obtained.
View full abstract